반응식
[CH3:1][C:2]1([CH3:14])[CH2:11][CH2:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([CH:12]=O)[CH:8]=2)[O:3]1.[CH3:15][C:16]1[CH:24]=[CH:23][CH:22]=[C:21]2[C:17]=1[CH2:18][C:19](=[O:25])[NH:20]2>>[CH3:1][C:2]1([CH3:14])[CH2:11][CH2:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([CH:12]=[C:18]3[C:17]4[C:21](=[CH:22][CH:23]=[CH:24][C:16]=4[CH3:15])[NH:20][C:19]3=[O:25])[CH:8]=2)[O:3]1참가 물질
3
실험 절차
2,2-Dimethyl-6-formylchromane (commercially available) was condensed with 4-methyl-2-oxindole to give 0.25 g of 3-(2,2-dimethylchroman-6-ylmethylene)-4-methyl-1,3-dihydroindol-2-one as a yellow-orange solid.
출처 및 근거
- ORD 기록
- ord-a7bd8554f2884268b4d3f6a5bb4a98e5
- 출처 데이터셋
- uspto-grants-2005_02
- 특허 번호
- US06855730B2
연결된 노트
불러오는 중…